Table 3.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in recurrent epithelial ovarian cancer.

Author	Year	N	OS	(months)	PFS	(months)
			Median	Mean	Median	Mean
Deraco et al. [97]	2001	27			21.8
Zanon et al. [98]	2004	30	28.1
Raspagliesi et al. [99]	2006	40		41.4		23.9
Helm et al. [100]	2007	18	31		10
Di Giorgio et al. [101]	2008	25	22.5		15.5
Fagotti et al. [102]	2009	25			10
Carrabin et al. [103]	2010	8			10
Spiliotis et al. [86]	2011	25	19.5		14.5

OS: overall survival; PFS: progression-free survival.